ZYBERNO
Stock Report
Updated Sep 1, 2026

Healthy Extracts Inc. (HYEX)

Healthcare • OTC

$1.17

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
37.0/100
WEAK BUSINESS
Healthy Extracts Inc. (HYEX) scores 37/100 — weak fundamentals with mixed indicators requiring careful analysis before acting.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):EXCELLENT (85.2%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.04x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (0.0%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

Healthy Extracts Inc. (HYEX) stock report — Zyberno Score 37/100 (WEAK BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:1.17
Market Cap:$17.25M

Valuation Multiples (3)

P/B Ratio:0.77x
P/S Ratio:2.74x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$17.48M

Price Action & Momentum (1)

% of 52-Week High:34.9%
B. Profitability Assessment

Margin Analysis (2)

Net Margin Ttm:319.9%
Ebitda Margin:0.0%

TTM Performance (2)

Gross Margin Ttm:61.1%
Net Margin Ttm:319.9%

Yield Metrics (2)

Earnings Yield:-$0.74
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:-100.0%
Latest Earnings Filed:2021-11-15

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):34.4%

Earnings Growth (Linear) (1)

Net Income Growth Rate (Linear):6.8%

Cash Flow Growth (Linear) (1)

Operating Cash Flow Growth Rate (Linear):64.4%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:0.20x
Quick Ratio:0.12x
Cash Ratio:0.02x

Leverage Analysis (3)

Debt To Equity Ttm:0.04x
Debt-to-Equity Ratio:0.04x
Debt To Ebitda:-999.00x

Coverage Ratios (1)

Times Interest Earned:-999.00

Capital Structure (4)

Working Capital:-6,709,619.00
Cash And Cash Equivalents:189,958.00
Long Term Debt:$229.11K
Net Debt:$235.97K
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $6.29M
Linear Growth: 34.4%
📊 Click to view full HYEX Revenue analysis & methodology →
Cost Of Revenue Ttm:$2.44M

Profitability Breakdown (2)

Gross profit TTM: $3.85M
Linear Growth: 34.1%
📊 Click to view full HYEX Gross Profit analysis & methodology →
$0.00

Bottom Line Performance (3)

Net income TTM: $20.12M
Linear Growth: 6.8%
📊 Click to view full HYEX Net Income analysis & methodology →
Income Before Tax:$0.00
Ebitda Ttm:0.00

Operating Expenses (5)

Operating Expenses:4,952,683.00
R And D Expense:0.00
Sga Expense:4,952,683.00
Income Tax Expense:$0.00
Interest Expense:-168,187.00

Expense Ratios (3)

R And D To Revenue Percentage:0.0%
Sga To Revenue Percentage:239.6%
Ebitda Margin:0.0%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$32.61M
Current Assets:$1.68M
Ppe Net:0.00
Goodwill:26,056,515.00
Intangible Assets:$3.88M

Liability Structure (4)

Total Liabilities:10,173,158.00
Current Liabilities:8,389,085.00
Long Term Debt:$229.11K
Short Term Debt:$196.82K

Equity & Capital (3)

Equity:$22.44M
Retained Earnings:-$20.45M
Common Stock:50,000,000.00

Working Capital Items (3)

Accounts Receivable:607,018.00
Inventory:644,114.00
Accounts Payable:340,515.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:0.00
C. Cash Flow Analysis

Operating Activities (2)

Operating cash flow TTM: $211.47K
Linear Growth: 64.4%
$0.00

Investment Activities (1)

Investing Cash Flow:$0.00

Financing Activities (3)

Financing Cash Flow:-$88.52K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-0.01
-$0.01
Earnings Per Share Ttm:$1.37

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.43
Operating Cash Flow Per Share:$0.01

Book Value & Capital (2)

Book Value Per Share:$1.52
Cash Per Share:0.01

Dividend Policy (1)

Dividend Payout Ratio:0.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.22x
Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:10.36x
Days Sales Outstanding Ttm:35.22

Inventory Management (2)

Inventory Turnover Ttm:3.79x
Days Inventory Outstanding Ttm:96.19

Payables & Cash Cycle (2)

Days Payable Outstanding:50.85
Cash Conversion Cycle:80.56
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:60.00
Quality Score:70.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (2)

Revenue Growth Rate (Linear):34.4%
Net Income Growth Rate (Linear):6.8%

Cash Flow Growth Rates (1)

Operating Cash Flow Growth Rate (Linear):64.4%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):34.1%
Book Value Growth Rate (Linear):57.9%
C. Company Profile & Context

Corporate Information (6)

Symbol:HYEX
Company Name:Healthy Extracts Inc.
Sector:Healthcare
Industry:Pharmaceuticals
Exchange:OTC
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:14.74M
Shares Outstanding Basic:14.74M
Shares Outstanding Diluted:0

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 05:29:32 UTC
Data Timestamp:2026-08-20T15:31:04.946100
Scroll to Top